Diiodohydroxyquinoline: Difference between revisions

	WikiDoc Resources for Diiodohydroxyquinoline
Articles
Most recent articles on Diiodohydroxyquinoline Most cited articles on Diiodohydroxyquinoline Review articles on Diiodohydroxyquinoline Articles on Diiodohydroxyquinoline in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Diiodohydroxyquinoline Images of Diiodohydroxyquinoline Photos of Diiodohydroxyquinoline Podcasts & MP3s on Diiodohydroxyquinoline Videos on Diiodohydroxyquinoline
Evidence Based Medicine
Cochrane Collaboration on Diiodohydroxyquinoline Bandolier on Diiodohydroxyquinoline TRIP on Diiodohydroxyquinoline
Clinical Trials
Ongoing Trials on Diiodohydroxyquinoline at Clinical Trials.gov Trial results on Diiodohydroxyquinoline Clinical Trials on Diiodohydroxyquinoline at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Diiodohydroxyquinoline NICE Guidance on Diiodohydroxyquinoline NHS PRODIGY Guidance FDA on Diiodohydroxyquinoline CDC on Diiodohydroxyquinoline
Books
Books on Diiodohydroxyquinoline
News
Diiodohydroxyquinoline in the news Be alerted to news on Diiodohydroxyquinoline News trends on Diiodohydroxyquinoline
Commentary
Blogs on Diiodohydroxyquinoline
Definitions
Definitions of Diiodohydroxyquinoline
Patient Resources / Community
Patient resources on Diiodohydroxyquinoline Discussion groups on Diiodohydroxyquinoline Patient Handouts on Diiodohydroxyquinoline Directions to Hospitals Treating Diiodohydroxyquinoline Risk calculators and risk factors for Diiodohydroxyquinoline
Healthcare Provider Resources
Symptoms of Diiodohydroxyquinoline Causes & Risk Factors for Diiodohydroxyquinoline Diagnostic studies for Diiodohydroxyquinoline Treatment of Diiodohydroxyquinoline
Continuing Medical Education (CME)
CME Programs on Diiodohydroxyquinoline
International
Diiodohydroxyquinoline en Espanol Diiodohydroxyquinoline en Francais
Business
Diiodohydroxyquinoline in the Marketplace Patents on Diiodohydroxyquinoline
Experimental / Informatics
List of terms related to Diiodohydroxyquinoline

Diiodohydroxyquinoline
Names
	IUPAC name 5,7-diiodoquinolin-8-ol
	Other names Diquinol, iodoxin, diiodoquin, amebaquin
Identifiers
CAS Number	83-73-8 ;
3D model (JSmol)	Interactive image;
ChEMBL	ChEMBL86754 ;
ChemSpider	3597 ;
ECHA InfoCard	Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value).
KEGG	D00581 ;
MeSH	Iodoquinol
PubChem CID	3728;
UNII	63W7IE88K8 ;
	InChI InChI=1S/C9H5I2NO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H Key: UXZFQZANDVDGMM-UHFFFAOYSA-N ; InChI=1/C9H5I2NO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H Key: UXZFQZANDVDGMM-UHFFFAOYAF;
	SMILES C1=CC2=C(C(=C(C=C2I)I)O)N=C1;
Properties
Chemical formula	C9H5I2NO
Molar mass	396.951
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
	verify (what is ?)
	Infobox references

VisualWikitext

Latest revision as of 13:39, 9 April 2015

Template:Chembox E number

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The quinoline derivative diiodohydroxyquinoline (INN) or iodoquinol (USAN), can be used in the treatment of amoebiasis. It is poorly absorbed from the gastrointestinal tract and is used as a luminal amebicide. It acts by chelation of ferrous ions essential for metabolism. It was discovered by Adco Co. and introduced as diiodohydroxyquinoline. Susceptibility of Dientamoeba fragilis has been measured. Iodoquinol is an amebocide used against Entamoeba histolytica, and it is active against both cysts and trophozoites that are localized in the lumen of the intestine. It is considered the drug of choice for treating asymptomatic or moderate forms of amebiasis. The mechanism of action is unknown. Iodoquinol is used for diseases caused by moderate intestinal amebiasis.

References

@@ Line 53: / Line 53: @@
 {{CMG}}
 ==Overview==
-The [[quinoline]] derivative '''diiodohydroxyquinoline''' ([[International Nonproprietary Name|INN]]) or '''iodoquinol''' ([[United States Adopted Name|USAN]]), can be used in the treatment of [[amoebiasis]].<ref name="pmid2493578">{{cite journal |author=Ghaskadbi S, Vaidya VG |title=In vivo antimutagenic effect of ascorbic acid against mutagenicity of the common antiamebic drug diiodohydroxyquinoline |journal=Mutat. Res. |volume=222 |issue=3 |pages=219–22 |date=March 1989 |pmid=2493578 |doi= 10.1016/0165-1218(89)90137-7|url=}}</ref>
+The [[quinoline]] derivative '''diiodohydroxyquinoline''' ([[International Nonproprietary Name|INN]]) or '''iodoquinol''' ([[United States Adopted Name|USAN]]), can be used in the treatment of [[amoebiasis]].
+It is poorly absorbed from the [[gastrointestinal tract]] and is used as a luminal amebicide. It acts by [[chelation]] of [[ferrous ion]]s essential for metabolism.
-It is poorly absorbed from the [[gastrointestinal tract]] and is used as a luminal amebicide. It acts by [[chelation]] of [[ferrous ion]]s essential for metabolism.<ref>{{cite web|url=http://web.gideononline.com/web/therapy/index.php?type=drugs&code=20130&view=General |work=Gideon Online}}</ref>
+It was discovered by Adco Co. and introduced as ''diiodohydroxyquinoline''.
+Susceptibility of ''[[Dientamoeba fragilis]]'' has been measured.
-It was discovered by Adco Co. and introduced as ''diiodohydroxyquinoline''.<ref>Page 1312. http://books.google.co.in/books?id=TIu28TH_iAYC&printsec=frontcover&source=gbs_ge_summary_r&cad=0#v=onepage&q&f=false</ref>
-Susceptibility of ''[[Dientamoeba fragilis]]'' has been measured.<ref name="pmid8067755">{{cite journal |author=Chan FT, Guan MX, Mackenzie AM, Diaz-Mitoma F |title=Susceptibility testing of Dientamoeba fragilis ATCC 30948 with iodoquinol, paromomycin, tetracycline, and metronidazole |journal=Antimicrob. Agents Chemother. |volume=38 |issue=5 |pages=1157–60 |date=May 1994 |pmid=8067755 |pmc=188168 |doi= 10.1128/aac.38.5.1157|url=http://aac.asm.org/cgi/pmidlookup?view=long&pmid=8067755}}</ref>
 Iodoquinol is an amebocide used against ''[[Entamoeba histolytica]]'', and it is active against both cysts and trophozoites that are localized in the lumen of the intestine. It is considered the drug of choice for treating asymptomatic or moderate forms of amebiasis. The mechanism of action is unknown. Iodoquinol is used for diseases caused by moderate intestinal amebiasis.

Diiodohydroxyquinoline: Difference between revisions

Latest revision as of 13:39, 9 April 2015

Overview

References

Navigation menu